Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
9.33
-0.13 (-1.37%)
At close: Jun 27, 2025, 4:00 PM
9.40
+0.07 (0.75%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Replimune Group Employees
Replimune Group had 479 employees as of March 31, 2025. The number of employees increased by 148 or 44.71% compared to the previous year.
Employees
479
Change (1Y)
148
Growth (1Y)
44.71%
Revenue / Employee
n/a
Profits / Employee
-$516,278
Market Cap
719.22M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
REPL News
- 22 days ago - Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 27 days ago - Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 4 weeks ago - Replimune to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Replimune Group, Inc. (REPL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Replimune Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day - GlobeNewsWire
- 7 weeks ago - Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Sibylla Biotech Appoints Former Bayer CEO, Dieter Weinand, as Chairman of the Board of Directors - GlobeNewsWire